WO2007021822A3 - Compositions and methods of preparation of liposomal microparticulate il-12 - Google Patents
Compositions and methods of preparation of liposomal microparticulate il-12 Download PDFInfo
- Publication number
- WO2007021822A3 WO2007021822A3 PCT/US2006/031173 US2006031173W WO2007021822A3 WO 2007021822 A3 WO2007021822 A3 WO 2007021822A3 US 2006031173 W US2006031173 W US 2006031173W WO 2007021822 A3 WO2007021822 A3 WO 2007021822A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compositions
- microparticulate
- liposomal
- preparation
- methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/208—IL-12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
This invention provides methods and compositions for localized delivery of IL- 12 to a desired site. The composition comprises liposomes carrying IL-12. The liposomes comprise phosphatidyl choline, phosphatidyl glycerol and cholesterol. The size and composition of the liposomes is such that there is minimal leakage into the systemic circulation. These compositions can be used for delivery of IL- 12 to selected sites such as tumors.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70665005P | 2005-08-09 | 2005-08-09 | |
US60/706,650 | 2005-08-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007021822A2 WO2007021822A2 (en) | 2007-02-22 |
WO2007021822A3 true WO2007021822A3 (en) | 2008-11-27 |
Family
ID=37758153
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2006/031173 WO2007021822A2 (en) | 2005-08-09 | 2006-08-09 | Compositions and methods of preparation of liposomal microparticulate il-12 |
Country Status (2)
Country | Link |
---|---|
US (1) | US7662405B2 (en) |
WO (1) | WO2007021822A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9693968B2 (en) | 2013-03-14 | 2017-07-04 | Jerome J. Schentag | Cholestosome vesicles for incorporation of molecules into chylomicrons |
CN107530291A (en) * | 2015-03-03 | 2018-01-02 | 奎尔波特股份有限公司 | Double heavy duty liposomal pharmaceutical preparations |
CN107530283A (en) | 2015-03-03 | 2018-01-02 | 奎尔波特股份有限公司 | Combine liposomal pharmaceutical preparation |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5908620A (en) * | 1995-01-31 | 1999-06-01 | National Jewish Medical And Research Center | Treatment for diseases involving inflammation |
US20010043914A1 (en) * | 1999-12-28 | 2001-11-22 | Edith Mathiowitz | Methods and products for tumor immunotherapy |
US6423308B1 (en) * | 1998-09-15 | 2002-07-23 | Wyeth | Treatment of Kaposi's sarcoma with IL-12 |
US6544549B1 (en) * | 1997-10-01 | 2003-04-08 | Biomira Usa Inc. | Multilamellar coalescence vesicles (MLCV) containing biologically active compounds |
US6787132B1 (en) * | 1997-12-04 | 2004-09-07 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Combined chemo-immunotherapy with liposomal drugs and cytokines |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4127502A (en) * | 1977-06-10 | 1978-11-28 | Eastman Kodak Company | Stabilizers for reconstituted, lyophilized samples |
US4795806A (en) * | 1987-07-16 | 1989-01-03 | Miles Laboratories, Inc. | Phospholipid affinity purification of Factor VIII:C |
US5580856A (en) * | 1994-07-15 | 1996-12-03 | Prestrelski; Steven J. | Formulation of a reconstituted protein, and method and kit for the production thereof |
EP0981548A4 (en) * | 1997-04-30 | 2005-11-23 | Enzon Inc | Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof |
US6033708A (en) * | 1997-09-30 | 2000-03-07 | The United States Of America As Represented By The Secretary Of The Navy | Method for producing sterile filterable liposome dispersion |
AU747391B2 (en) * | 1998-04-27 | 2002-05-16 | Cantab Biopharmaceuticals Patents Limited | Pharmaceutical composition comprising factor VIII and neutral liposomes |
AU2002239607A1 (en) * | 2000-11-30 | 2002-06-11 | Baxter Healthcare Corporation | Ahf associated dispersion system and method for preparation |
ZA200305980B (en) * | 2001-02-12 | 2007-01-31 | Res Dev Foundation | Modified proteins, designer toxins, and methods of making thereof |
WO2003013245A1 (en) | 2001-08-07 | 2003-02-20 | Wisconsin Alumni Research Foundation | Polyamines and analogs for protecting cells during cancer chemotherapy and radiotherapy |
US20040247661A1 (en) * | 2002-07-03 | 2004-12-09 | Dov Michaeli | Liposomal vaccine |
WO2004071420A2 (en) * | 2003-02-05 | 2004-08-26 | The Research Foundation Of State University Of New York | Compositions and methods for less immunogenic protein formulations |
EP1624857A2 (en) * | 2003-05-12 | 2006-02-15 | Novosom AG | Injectable depots consisting of liposomal aggregates for the delivery of active substances |
US7939058B2 (en) * | 2003-07-03 | 2011-05-10 | University Of Southern California | Uses of IL-12 in hematopoiesis |
-
2006
- 2006-08-09 US US11/502,206 patent/US7662405B2/en active Active
- 2006-08-09 WO PCT/US2006/031173 patent/WO2007021822A2/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5908620A (en) * | 1995-01-31 | 1999-06-01 | National Jewish Medical And Research Center | Treatment for diseases involving inflammation |
US6544549B1 (en) * | 1997-10-01 | 2003-04-08 | Biomira Usa Inc. | Multilamellar coalescence vesicles (MLCV) containing biologically active compounds |
US6787132B1 (en) * | 1997-12-04 | 2004-09-07 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Combined chemo-immunotherapy with liposomal drugs and cytokines |
US6423308B1 (en) * | 1998-09-15 | 2002-07-23 | Wyeth | Treatment of Kaposi's sarcoma with IL-12 |
US20010043914A1 (en) * | 1999-12-28 | 2001-11-22 | Edith Mathiowitz | Methods and products for tumor immunotherapy |
Also Published As
Publication number | Publication date |
---|---|
US20070071804A1 (en) | 2007-03-29 |
US7662405B2 (en) | 2010-02-16 |
WO2007021822A2 (en) | 2007-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2011076807A3 (en) | Lipids, lipid compositions, and methods of using them | |
WO2005112633A3 (en) | Compounds and compositions for delivering active agents | |
EP2695608A3 (en) | Lipid containing formulations | |
WO2007064857A3 (en) | Amphoteric liposome formulation | |
WO2007111720A8 (en) | Formulation of insoluble small molecule therapeutics in lipid-based carriers | |
NZ711583A (en) | Lipid compositions | |
WO2007149287A3 (en) | Transfer factor compositions and methods | |
WO2007124090A3 (en) | Lyophilized therapeutic peptibody formulations | |
WO2005070090A3 (en) | Regulatory t cells suppress autoimmunity | |
WO2002070438A3 (en) | Compositions for delivering bisphosphonates | |
WO2008030567A3 (en) | Dry powder compound formulations and uses thereof | |
WO2010088537A3 (en) | Improved lipid formulation for the delivery of nucleic acids | |
WO2002080965A3 (en) | Vaccine composition | |
HK1103391A1 (en) | Cationic lipids and methods of use | |
WO2008011272A3 (en) | Liquid monophasic lipid-soluble antioxidant compositions and processes for making the compositions | |
WO2007076144A3 (en) | Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof | |
WO2008070463A3 (en) | Endoxifen methods and compositions | |
WO2006055352A3 (en) | Methods of treating cancer with lipid-based platinum compound formulations administered intraperitoneally | |
WO2008072954A3 (en) | Liposomes containing a polyphenol derivative such as caffeic acid and a method of post-loading thereof | |
WO2006069719A3 (en) | Lyophilization of virosomes | |
WO2006065861A3 (en) | Therapeutic formulations of keratinocyte growth factor | |
WO2006068759A3 (en) | Liposomes containing phytochemical agents and methods for making and using same | |
WO2006053250A3 (en) | Lipase inhibitors | |
WO2007067519A3 (en) | The use of neurotransmitters and neuropeptides for the treatment of dry eye diseases and related conditions | |
WO2007021822A3 (en) | Compositions and methods of preparation of liposomal microparticulate il-12 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06801121 Country of ref document: EP Kind code of ref document: A2 |